InvestorsHub Logo
Followers 55
Posts 2608
Boards Moderated 0
Alias Born 02/04/2014

Re: Emmmci post# 34361

Monday, 04/13/2015 5:07:17 PM

Monday, April 13, 2015 5:07:17 PM

Post# of 144814
"I am honored to be named AZ Business magazine's Researcher of the Year, especially in light of the other fine physician-scientists nominated," said Dr. Von Hoff. "Our work in translation of laboratory discoveries into clinical trials is vitally important for the many patients who we all strive to help."

"Two additional clinical trials will be conducted in the U.S. by Translational Drug Development (TD2). These trials will determine the effectiveness of PharmaCyte Biotech’s treatment in (i) reducing the severe pain that occurs in patients with advanced pancreatic cancer; and (ii) slowing the accumulation of malignant fluid (ascites) that accompanies the development of pancreatic and other solid cancerous tumors in the abdomen."

I admire him. He is a man of purpose and compassion.

http://www.pharmacytebiotech.com/pharmacyte-biotech-on-track-to-commence-clinical-trials/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News